BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27355222)

  • 1. Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluation.
    Stevenson M; Pandor A; Martyn-St James M; Rafia R; Uttley L; Stevens J; Sanderson J; Wong R; Perkins GD; McMullan R; Dark P
    Health Technol Assess; 2016 Jun; 20(46):1-246. PubMed ID: 27355222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation.
    Corbett M; Duarte A; Llewellyn A; Altunkaya J; Harden M; Harris M; Walker S; Palmer S; Dias S; Soares M
    Health Technol Assess; 2020 Aug; 24(39):1-248. PubMed ID: 32840478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective multicenter evaluation of direct molecular detection of blood stream infection from a clinical perspective.
    Nieman AE; Savelkoul PHM; Beishuizen A; Henrich B; Lamik B; MacKenzie CR; Kindgen-Milles D; Helmers A; Diaz C; Sakka SG; Schade RP
    BMC Infect Dis; 2016 Jun; 16():314. PubMed ID: 27364885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of LightCycler(R) SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review protocol.
    Dark P; Wilson C; Blackwood B; McAuley DF; Perkins GD; McMullan R; Gates S; Warhurst G
    BMJ Open; 2012; 2(1):e000392. PubMed ID: 22240646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culture-independent identification of bloodstream infections from whole blood: prospective evaluation in specimens of known infection status.
    Iyer V; Castro D; Malla B; Panda B; Rabson AR; Horowitz G; Heger N; Gupta K; Singer A; Norwitz ER
    J Clin Microbiol; 2024 Mar; 62(3):e0149823. PubMed ID: 38315022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Cost-effectiveness of Early Identification of Hospital-acquired Infection in Critically Ill Patients.
    Tsalik EL; Li Y; Hudson LL; Chu VH; Himmel T; Limkakeng AT; Katz JN; Glickman SW; McClain MT; Welty-Wolf KE; Fowler VG; Ginsburg GS; Woods CW; Reed SD
    Ann Am Thorac Soc; 2016 Mar; 13(3):401-13. PubMed ID: 26700878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting community acquired bloodstream infection in infants using full blood count parameters and C-reactive protein; a machine learning study.
    Brouwer L; Cunney R; Drew RJ
    Eur J Pediatr; 2024 Jul; 183(7):2983-2993. PubMed ID: 38634890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in synthesising cost-effectiveness estimates.
    Shields GE; Elvidge J
    Syst Rev; 2020 Dec; 9(1):289. PubMed ID: 33298168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and External Validation of the Ottawa Bloodstream Infection Model for Acutely Ill Adults.
    Hryciw BN; Rodic S; Selim S; Wang C; Lepage MF; Nguyen LH; Goyal V; van Walraven C
    J Gen Intern Med; 2024 Jan; 39(1):103-112. PubMed ID: 37723368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer's perspective.
    Gandjour A
    BMC Health Serv Res; 2022 Jan; 22(1):47. PubMed ID: 35000587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FilmArray (BCID2) provides essential and timely results in bloodstream infections in small acute care hospitals without conventional microbiology services.
    Harboe-Sjåvik H; Endresen KH; Åsheim S; Sundsfjord A
    APMIS; 2024 Apr; 132(4):267-276. PubMed ID: 38214228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit.
    Murray PR; Masur H
    Crit Care Med; 2012 Dec; 40(12):3277-82. PubMed ID: 23034460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential impact of a new sepsis prediction model for the primary care setting: early health economic evaluation using an observational cohort.
    Loots FJ; van der Meulen MP; Smits M; Hopstaken RM; de Bont EG; van Bussel BC; Latten GH; Oosterheert JJ; van Zanten AR; Verheij TJ; Frederix GW
    BMJ Open; 2024 Jan; 14(1):e071598. PubMed ID: 38233050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of Next-Generation Sequencing in Diagnosis and Therapy of Critically Ill Patients with Suspected Bloodstream Infections: A Retrospective Cohort Study.
    Overbeek R; Leitl CJ; Stoll SE; Wetsch WA; Kammerer T; Mathes A; Böttiger BW; Seifert H; Hart D; Dusse F
    J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the diagnostic accuracy of PCR-reverse blot hybridization assay and conventional fungus study in superficial fungal infection of the skin: A systematic review.
    Jeon JJ; Kim YH; Lim SH; Lee S; Choi EH
    Mycoses; 2024 Jan; 67(1):e13678. PubMed ID: 38214426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melting temperature mapping method in children: Rapid identification of pathogenic microbes.
    Ishikawa T; Uejima Y; Okai M; Shiga K; Shoji K; Miyairi I; Kato M; Morooka S; Kubota M; Tagaya T; Tsuji S; Aoki S; Ide K; Niimi H; Uchiyama T; Onodera M; Kawai T
    J Infect Chemother; 2024 Jun; 30(6):475-480. PubMed ID: 38036030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the biases to sepsis surveillance and quality assurance caused by inaccurate coding in administrative health data.
    Schwarzkopf D; Rose N; Fleischmann-Struzek C; Boden B; Dorow H; Edel A; Friedrich M; Gonnert FA; Götz J; Gründling M; Heim M; Holbeck K; Jaschinski U; Koch C; Künzer C; Le Ngoc K; Lindau S; Mehlmann NB; Meschede J; Meybohm P; Ouart D; Putensen C; Sander M; Schewe JC; Schlattmann P; Schmidt G; Schneider G; Spies C; Steinsberger F; Zacharowski K; Zinn S; Reinhart K
    Infection; 2024 Apr; 52(2):413-427. PubMed ID: 37684496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Effectiveness of Genomic Population Health Screening in Adults: A Review of Modeling Studies and Future Directions.
    Wildin RS
    J Appl Lab Med; 2024 Jan; 9(1):92-103. PubMed ID: 38167759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of collegiate recovery programs.
    Castedo de Martell S; Holleran Steiker L; Springer A; Jones J; Eisenhart E; Brown Iii HS
    J Am Coll Health; 2024 Jan; 72(1):82-93. PubMed ID: 35080467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling test and treatment strategies for presymptomatic Alzheimer disease.
    Burke JF; Langa KM; Hayward RA; Albin RL
    PLoS One; 2014; 9(12):e114339. PubMed ID: 25474698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.